Evaluación de Tecnologías Sanitarias

Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region

Augustovski F, Iglesias C, Manca A, Drummond M, Rubinstein A, Marti SG. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region. Pharmacoeconomics. 2009;27(11):919-929.

Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region Ver más »

Good research practices for measuring drug costs in cost-effectiveness analyses: an international perspective: the ISPOR Drug Cost Task Force report–Part VI

L. Z. Shi,M. Hodges,M. Drummond,J. Ahn,S. C. Li,S. L. Hu,F. Augustovski,J. W. Hay and J. Smeeding. Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: An International Perspective: The ISPOR Drug Cost Task Force Report-Part VI. Value in Health. 2010;13(1):10.1111/j.1524-4733.2009.00662.x.

Good research practices for measuring drug costs in cost-effectiveness analyses: an international perspective: the ISPOR Drug Cost Task Force report–Part VI Ver más »

Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries

Colantonio L, Gomez JA, Demarteau N, Standaert B, Pichon-Riviere A, Augustovski F. Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries. Vaccine. 2009;27(40):5519-5529.

Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries Ver más »

Development and implementation of health technology assessment in Argentina: two steps forward and one step back

Rubinstein A, Pichon-Riviere A, Augustovski F. Development and implementation of health technology assessment in Argentina: two steps forward and one step back. Int J Technol Assess Health Care. 2009;25 Suppl 1:260-269.

Development and implementation of health technology assessment in Argentina: two steps forward and one step back Ver más »

Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina

Rubinstein A, Garcia Marti S, Souto A, Ferrante D, Augustovski F. Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina. Cost Eff Resour Alloc. 2009;7:10.

Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina Ver más »

Cost-effectiveness analysis of entecavir versus lamivudine in patients with chronic hepatitis B

Calcagno JI, Augustovski F, Gadano A, Souto A, Yuan Y. [Cost-effectiveness analysis of entecavir versus lamivudine in patients with chronic hepatitis B]. Acta Gastroenterol Latinoam. 2008;38(4):260-273.

Cost-effectiveness analysis of entecavir versus lamivudine in patients with chronic hepatitis B Ver más »

Supporting the delivery of cost-effective interventions in primary health-care systems in low-income and middle-income countries: an overview of systematic reviews

Lewin S, Lavis JN, Oxman AD, et al. Supporting the delivery of cost-effective interventions in primary health-care systems in low-income and middle-income countries: an overview of systematic reviews. Lancet. 2008;372(9642):928-939.

Supporting the delivery of cost-effective interventions in primary health-care systems in low-income and middle-income countries: an overview of systematic reviews Ver más »